Colostrum vs Transitional Milk: How Composition Shifts

Colostrum and transitional milk are two distinct stages of the same evolving fluid, each tuned to what a newborn needs at a specific moment. Colostrum, produced in the first two to five days after birth, is thick, yellowish, and packed with immune factors, while transitional milk fills the gap between colostrum and the arrival of mature milk, typically spanning days five through fourteen. The shift between them is gradual rather than abrupt, and it involves measurable changes in protein, fat, sugar, immune cells, hormones, and even the bacteria living in the milk itself.

When One Becomes the Other

There is no single morning when colostrum “turns into” transitional milk. The changeover happens along a continuum driven by hormonal shifts after delivery of the placenta. Progesterone drops, prolactin surges, and the mammary gland steadily ramps up volume while dialing down the concentration of many protective compounds. Most clinical definitions mark colostrum as the secretion collected in roughly the first 72 hours postpartum, transitional milk as what follows until about day 14, and mature milk as everything after that. These cutoffs are useful for research, but in practice, one stage bleeds into the next.

How the Macronutrients Shift

Colostrum is comparatively low in volume but high in protein and minerals. As lactation progresses into the transitional phase, protein concentration drops, fat content adjusts, and lactose rises to fuel the infant’s rapidly increasing caloric needs. A study tracking these changes found that solids-not-fat, fat percentage, protein percentage, and ash all decreased over time, while pH gradually climbed.¹ The practical result is a fluid that goes from small, dense, and protein-rich to larger in volume, slightly more dilute in protein, and richer in the lactose that will eventually be the baby’s primary carbohydrate source.

The protein story is especially striking. Colostrum can contain two to three times the protein concentration of mature milk. Much of that extra protein is not there for nutrition; it is immunoglobulin, lactoferrin, and other defense molecules that coat the infant’s gut. As the transitional phase kicks in, overall protein drops, but the ratio of nutritive whey proteins and casein begins shifting toward what the baby needs for growth rather than purely for immune defense.

The Immunoglobulin Handoff

The immune protection in human milk changes character as the days pass. In colostrum, IgA is the dominant immunoglobulin, with an average concentration measured at roughly 5.9 g/L in one study of Bangladeshi mothers. By the transitional stage, IgA had fallen to about 3.9 g/L, and it settled near 3.7 g/L in mature milk.² IgM followed a similar downward trend. But IgG went the opposite direction, rising from colostrum into transitional and mature milk. That same pattern has been confirmed in studies of mothers delivering at different gestational ages, where IgA peaked in colostrum and then dropped through the transitional period regardless of whether the baby was born early or on time.³

This does not mean transitional milk is “weaker.” IgA still dwarfs the other immunoglobulins even at lower concentrations, and the baby compensates by drinking much more volume during the transitional stage than during the colostral phase. Total daily IgA delivery may actually hold fairly steady or even rise.

Lactoferrin and Lysozyme Follow Their Own Curves

Beyond immunoglobulins, two other defense molecules deserve attention because they behave differently from each other and from the antibodies. Lactoferrin, an iron-binding protein that starves bacteria of the iron they need to grow, starts high in colostrum at about 5.8 g/L, drops to roughly 3.1 g/L in transitional milk, and continues falling to about 2.0 g/L in the first month of mature milk. After that, it actually rises again, reaching about 3.3 g/L by the second to third month.⁴ Lysozyme, an enzyme that attacks bacterial cell walls, follows a similar dip-then-rebound pattern, falling from 0.37 g/L in colostrum to 0.27 g/L in transitional milk before climbing all the way to 0.89 g/L by months two to three.

The rebound is interesting because it means the immune profile of mature milk is not simply a diluted version of colostrum. Later milk appears to increase production of certain antimicrobial molecules on its own schedule, possibly in response to the infant’s growing exposure to environmental microbes. So while colostrum clearly wins the overall concentration game, transitional and mature milk each bring their own protective character to the table.

Human Milk Oligosaccharides and Gut Priming

Human milk oligosaccharides, or HMOs, are complex sugars that the baby cannot digest. They exist to feed beneficial gut bacteria and to act as decoys that bind pathogens before those pathogens can latch onto intestinal cells. Colostrum contains a higher total HMO concentration than mature milk. One study measured total HMOs at about 10.3 g/L in colostrum compared to roughly 6.8 g/L in mature samples.⁵ The specific HMO profile also shifts: certain fucosylated types like 2′-FL are more concentrated in colostrum, while 3′-FL rises in mature milk. Sialylated types, which are thought to play roles in brain development, tend to be more concentrated earlier and decline as milk matures.

These shifting profiles are not random. Research has found regular changing trajectories in HMO composition and relative abundance as postpartum days progress, with significant differences between the colostral, transitional, and mature stages.⁶ The early high-dose delivery in colostrum likely helps seed the infant’s gut with the right bacterial communities during a critical window when the intestinal lining is most permeable.

Living Cells in the Milk

Both colostrum and transitional milk contain living cells, but their makeup changes over time. Colostrum is unusually rich in immune cells, including neutrophils, macrophages, and lymphocytes, along with stem cells. As milk transitions toward maturity, total immune cell percentages drop, and the balance among immune cell subtypes shifts. A study characterizing stem cells and immune cells across lactation stages found that the percentages of total immune cells were lower in mature milk than in colostrum and that the proportions of hematopoietic stem cells and major immune cell populations changed dynamically.⁷

Even in dairy animals, where these dynamics have been studied in finer detail, the same general pattern holds: lymphocyte proportion increases as colostrum transitions to mature milk, but overall somatic cell numbers decline at the same time.⁸ In plain terms, the early flood of immune cells in colostrum gives way to a more targeted cellular defense that relies on fewer cells but a higher proportion of lymphocytes, the cells that mount specific immune responses.

The Bacterial Community Inside the Milk

Human milk is not sterile. It carries its own microbiome, and the composition of that microbial community changes as milk matures. Colostrum has the lowest bacterial diversity compared to transitional and mature milk. A study tracking this found that microbial diversity and richness progressively escalated from colostrum through transitional to mature milk, with statistically significant differences across all standard diversity measures.⁹ The bacterial species present also shifted, with different communities dominating at each stage.

This makes biological sense when you consider what is happening on the other end: the baby’s gut is progressively colonized by more diverse bacteria over the same time frame. The milk microbiome appears to co-evolve with the infant’s needs, starting with a narrow, concentrated set of organisms in colostrum and broadening as the baby’s own gut ecosystem becomes more complex. These bacteria do not simply ride passively in the milk; they interact with the HMOs described earlier, creating a feedback loop in which the prebiotics and probiotics in milk work together to establish the infant’s gut flora.

What Changes When Babies Arrive Early

Preterm birth alters the composition of both colostrum and transitional milk in ways that partly compensate for the baby’s greater vulnerability. Mothers of very preterm infants produce colostrum and transitional milk with higher fat content than mothers delivering at term. They also produce higher proportions of medium-chain saturated fatty acids, which are easier for an immature gut to absorb.¹⁰

The amino acid profile also diverges. A comparative analysis of free amino acids found significant differences between term and preterm breast milk. Glutamic acid, the most abundant free amino acid in all samples, was about 82% higher in term milk. Preterm milk, by contrast, was enriched in branched-chain amino acids like leucine and isoleucine and in aspartic acid.¹¹ These branched-chain amino acids are building blocks for muscle and organ growth, which is especially critical for babies who left the womb early.

Colostrum in the NICU

Because colostrum is so concentrated in immune factors, neonatal intensive care units have experimented with giving tiny amounts of it directly to the mouths of very preterm infants who cannot yet tolerate regular feeding. This practice, called oropharyngeal administration of colostrum, involves placing drops of colostrum on the baby’s inner cheeks and tongue. A pilot trial in infants born at 32 weeks or earlier found that the group receiving oropharyngeal colostrum had lower rates of necrotizing enterocolitis (about 2% versus 10%) and lower rates of late-onset sepsis (about 5% versus 14%) compared to controls, with no adverse reactions.¹² The colostrum group also reached full enteral feeding faster.

The evidence is promising but not yet settled. Another randomized trial looking at oral application of colostrum in preterm infants found no significant differences in mortality, necrotizing enterocolitis, or several other outcomes.¹³ Differences in timing, dose, and the specific populations studied likely explain the conflicting results. What both trials agree on is safety: oropharyngeal colostrum does not appear to cause harm, which is why many NICUs have adopted it as a low-risk, potentially high-reward practice while larger confirmatory trials continue.

How Maternal Health Shapes the Milk

The composition of colostrum and transitional milk is not identical from mother to mother. Gestational diabetes, for example, alters the metabolic profile of all three milk stages. Research has shown that mothers with gestational diabetes produce colostrum, transitional milk, and mature milk with significantly different free fatty acid profiles compared to healthy controls. While free amino acids were broadly similar between the two groups, a number of free fatty acids declined in the gestational diabetes group.¹⁴ Because free fatty acids are building blocks for fat tissue and neurons, disturbed fatty acid composition in breast milk could potentially affect neonatal development if the baby is exclusively breastfed. The researchers noted that formula supplementation for these infants might need careful adjustment of its fatty acid composition.

Parity matters as well. First-time mothers and experienced mothers do not produce identical colostrum. In dairy cows, where this has been quantified precisely, first-parity animals produced colostrum with lower IgG concentrations than multiparous animals.¹⁵ Human data suggest a similar trend, although the differences are subtler and influenced by many confounding factors like maternal infection history and vaccination status.

Antioxidant Capacity and Hormonal Content

Colostrum does not just outpace transitional milk in immune factors. It also has drastically higher antioxidant capacity, including greater hydroxyl radical scavenging ability and higher glutathione reductase activity compared to mature milk. These antioxidants help protect the newborn’s tissues during the oxidative stress of adapting to breathing air for the first time. As milk transitions through the first two weeks, these antioxidant defenses naturally taper, coinciding with the baby’s own developing antioxidant systems.

Hormones like prolactin and cortisol are also present in colostrum and decrease exponentially after the first milking or expression, tracking closely with the shift from colostrum to transitional milk.¹⁶ While the exact role of milk-borne hormones in infant metabolism is still being studied, the steep early decline suggests they play a time-sensitive role in the newborn’s metabolic regulation during the first days of life.

Oligosaccharides Beyond Human Milk

The colostrum-to-transitional shift in oligosaccharides is not unique to humans. Bovine colostrum also contains elevated concentrations of specific oligosaccharides compared to later milk, particularly sialylated types like 3′-sialyllactose, 6′-sialyllactose, and 6′-sialyllactosamine. These concentrations decline rapidly through the first several milkings as colostrum gives way to transitional and then mature milk.¹⁷ This cross-species consistency hints at a deeply conserved biological strategy: front-load the gut-priming sugars when the newborn’s intestine is most vulnerable, then shift resources toward calorie delivery as the gut matures and bacterial colonization stabilizes.

The commercial interest in bovine colostrum partly stems from this oligosaccharide richness. Supplement companies market bovine colostrum capsules and powders to adults for purported gut-health and immune benefits. Whether those benefits translate meaningfully to an adult human digestive tract, which is far more developed and already colonized, is another question entirely. The research that documents colostrum’s protective power is almost entirely about newborns with immature guts, not grown adults with established microbiomes.

Gut Barrier Function in the First Days

One of the less visible but most consequential roles of colostrum is its effect on the integrity of the intestinal lining. Neonatal intestines are highly permeable, which is useful for absorbing large immune molecules like IgA but also makes the baby vulnerable to harmful bacteria slipping through. Research in neonatal calves has shown that colostrum feeding, compared to formula, increases the expression of genes related to toll-like receptors and tight-junction proteins in the small intestine, suggesting improved immune responsiveness and stronger epithelial barrier function.¹⁸ Tight-junction proteins are the molecular “rivets” that hold intestinal cells together, and their upregulation in response to colostrum helps close the permeability window faster.

By the time milk transitions into the transitional phase, the infant gut has already begun tightening up. This is part of why the colostral window is considered so critical: the combination of high IgA, high lactoferrin, concentrated HMOs, and the barrier-strengthening signals in colostrum all work in concert during a narrow period when the baby’s defenses are at their most rudimentary. Missing colostrum entirely does not doom a child, but it removes a coordinated set of inputs that the gut appears specifically primed to receive in the first days of life.

Why “Liquid Gold” Is Not the Whole Story

Colostrum’s nickname as “liquid gold” has entered popular culture so thoroughly that transitional milk sometimes gets treated as an afterthought, a mere dilution en route to the real product. That framing undersells what transitional milk actually does. The rising volume of transitional milk matches the newborn’s expanding stomach capacity, which roughly doubles in the first week. Its higher lactose content provides the energy a baby needs as metabolic demands increase. And the fact that certain immune components like IgG actually rise during the transition suggests that the body is not simply running out of colostral ingredients; it is deliberately shifting the immune strategy from broad mucosal coating (IgA-heavy) toward systemic immune support (IgG-heavy).

Transitional milk also bridges a period when the infant’s own immune system is beginning to wake up. The bacterial diversity of the milk is increasing, seeding the gut with a wider range of organisms. The HMO profile is adjusting to support different bacterial communities. And the rising lactose provides fuel not just for the baby but for the lactobacilli and bifidobacteria that are becoming the dominant residents of the infant gut. Transitional milk is not a watered-down version of colostrum. It is the next chapter in a carefully staged biological handoff.